BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37758809)

  • 1. The bisphosphonates alendronate and zoledronate induce adaptations of aerobic metabolism in permanent human endothelial cells.
    Budzinska A; Galganski L; Jarmuszkiewicz W
    Sci Rep; 2023 Sep; 13(1):16205. PubMed ID: 37758809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
    Oizumi T; Funayama H; Yamaguchi K; Yokoyama M; Takahashi H; Yamamoto M; Kuroishi T; Kumamoto H; Sasaki K; Kawamura H; Sugawara S; Endo Y
    J Oral Maxillofac Surg; 2010 May; 68(5):1043-54. PubMed ID: 20156665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Statins on the Aerobic Metabolism of Endothelial Cells.
    Broniarek I; Dominiak K; Galganski L; Jarmuszkiewicz W
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia and aerobic metabolism adaptations of human endothelial cells.
    Koziel A; Jarmuszkiewicz W
    Pflugers Arch; 2017 Jun; 469(5-6):815-827. PubMed ID: 28176017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells.
    Ribeiro V; Garcia M; Oliveira R; Gomes PS; Colaço B; Fernandes MH
    J Cell Mol Med; 2014 Jan; 18(1):27-37. PubMed ID: 24373581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chronic exposure to high palmitic acid concentrations on the aerobic metabolism of human endothelial EA.hy926 cells.
    Broniarek I; Koziel A; Jarmuszkiewicz W
    Pflugers Arch; 2016 Sep; 468(9):1541-54. PubMed ID: 27417103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.
    Jung J; Park JS; Righesso L; Pabst AM; Al-Nawas B; Kwon YD; Walter C
    Clin Oral Investig; 2018 Sep; 22(7):2527-2534. PubMed ID: 29388023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
    Oizumi T; Yamaguchi K; Funayama H; Kuroishi T; Kawamura H; Sugawara S; Endo Y
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells.
    Tanaka Y; Nagai Y; Dohdoh M; Oizumi T; Ohki A; Kuroishi T; Sugawara S; Endo Y
    Arch Oral Biol; 2013 Jun; 58(6):628-37. PubMed ID: 23245859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
    Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
    Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 Alleviates Chronic Nucleoside Reverse Transcriptase Inhibitor-Induced Premature Endothelial Senescence.
    Chen YF; Hebert VY; Stadler K; Xue SY; Slaybaugh K; Luttrell-Williams E; Glover MC; Krzywanski DM; Dugas TR
    Cardiovasc Toxicol; 2019 Dec; 19(6):500-509. PubMed ID: 31020509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice: involvement of mevalonate pathway, TNFalpha, macrophages, and T-cells.
    Deng X; Yu Z; Funayama H; Yamaguchi K; Sasano T; Sugawara S; Endo Y
    Int Immunopharmacol; 2007 Feb; 7(2):152-61. PubMed ID: 17178381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of high glucose on the aerobic metabolism of endothelial EA.hy926 cells.
    Koziel A; Woyda-Ploszczyca A; Kicinska A; Jarmuszkiewicz W
    Pflugers Arch; 2012 Dec; 464(6):657-69. PubMed ID: 23053476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.
    Luckman SP; Hughes DE; Coxon FP; Graham R; Russell G; Rogers MJ
    J Bone Miner Res; 1998 Apr; 13(4):581-9. PubMed ID: 9556058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
    Hasmim M; Bieler G; Rüegg C
    J Thromb Haemost; 2007 Jan; 5(1):166-73. PubMed ID: 17059425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates.
    Kimmel DB
    J Dent Res; 2007 Nov; 86(11):1022-33. PubMed ID: 17959891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pH on osteoclasts treated with zoledronate and alendronate.
    Manzano-Moreno FJ; Ramos-Torrecillas J; de Luna-Bertos E; Illescas-Montes R; Arnett TR; Ruiz C; García-Martínez O
    Clin Oral Investig; 2019 Feb; 23(2):813-820. PubMed ID: 29876664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts.
    Giannasi C; Niada S; Farronato D; Lombardi G; Manfredi B; Farronato G; Brini AT
    Int J Med Sci; 2019; 16(1):23-32. PubMed ID: 30662325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt.
    Bezzi M; Hasmim M; Bieler G; Dormond O; Rüegg C
    J Biol Chem; 2003 Oct; 278(44):43603-14. PubMed ID: 12933798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.